FAIZA SHAIKH: Open Payments
NPI 1740912484 · FAIR LAWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 48 payments from 12 companies in 2025. Trend: 2023 $1,553 · 2024 $1,435 · 2025 $974
Food & beverage: $965Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $250 |
| Ardelyx, Inc. | 11 | $227 |
| Janssen Biotech, Inc. | 10 | $226 |
| Gilead Sciences, Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Exact Sciences Corporation | 1 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| EVOKE PHARMA, INC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
Products named: IBSRELA, TREMFYA, SKYRIZI, LINZESS, RINVOQ, CREON, EOHILIA, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
